ConductScience.org, home

Paper467467

Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.

Pechere JC and 2 others. Eur J Drug Metab Pharmacokinet, 1979. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis. Papers, record 467467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/467467

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
PubMed
Journal
Eur J Drug Metab Pharmacokinet
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pechere JCJ C
2Dugal RR
3Pechere MMM M

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
KanamycinMajor topic
Renal DialysisMajor topic
Adult
Biotransformation
Female
Half-Life
Humans
Infusions, Parenteral
Injections, Intravenous
Kidney Failure, Chronic
Kinetics
Male
Middle Aged
Time Factors

Source PubMed

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1993,624Clinical pharmacology of amikacin and kanamycin.J Infect Dis1976https://conductscience.org/library/papers/993624PubMed
25,652,110Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.J Pharm Sci1968https://conductscience.org/library/papers/5652110PubMed
3690,033Disposition studies with amikacin after rapid intravenous and intramuscular administration to human volunteers.J Antimicrob Chemother1978https://conductscience.org/library/papers/690033PubMed
4984,789Effect of renal failure and dialysis on the serum concentration of the aminoglycoside amikacin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984789PubMed
54,451,356Pharmacokinetics of gentamicin and kanamycin during hemodialysis.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4451356PubMed
61,002,369Distribution and elimination kinetics of intravenously and intramusculary administered tobramycin in man.Int J Clin Pharmacol Biopharm1976https://conductscience.org/library/papers/1002369PubMed
7792,360A review of results of clinical trials with amikacin.J Infect Dis1976https://conductscience.org/library/papers/792360PubMed
84,959,982Simplified, accurate method for antibiotic assay of clinical specimens.Appl Microbiol1966https://conductscience.org/library/papers/4959982PubMed
9825,583Discovery, chemistry, and activity of amikacin.J Infect Dis1976https://conductscience.org/library/papers/825583PubMed
10938,024Ototoxicity of amikacin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/938024PubMed
111,102,570Correlation of serum creatinine concentration and amikacin half-life.J Clin Pharmacol1975https://conductscience.org/library/papers/1102570PubMed
12602,958A comparative trial of sisomicin therapy by intermittent versus continuous infusion.Am J Med Sci1977https://conductscience.org/library/papers/602958PubMed
13993,627Pharmacokinetics of amikacin in patients with impaired renal function.J Infect Dis1976https://conductscience.org/library/papers/993627PubMed
14993,628Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function.J Infect Dis1976https://conductscience.org/library/papers/993628PubMed
15972,269Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.J Infect Dis1976https://conductscience.org/library/papers/972269PubMed
16848,923Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/848923PubMed
17825,589Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.J Infect Dis1976https://conductscience.org/library/papers/825589PubMed
18993,625Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay.J Infect Dis1976https://conductscience.org/library/papers/993625PubMed
194,790,604Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790604PubMed
20134,142CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.J Pharm Sci1976https://conductscience.org/library/papers/134142PubMed

See all 30 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
30,147,136Intravenous Push Administration of Antibiotics: Literature and Considerations.Hosp Pharm2018https://conductscience.org/library/papers/30147136PubMed
3,169,115Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3169115PubMed
383,354Clinical pharmacokinetics of aminoglycoside antibiotics.Clin Pharmacokinet1979https://conductscience.org/library/papers/383354PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/467467

GET https://conductscience.org/api/papers/v1/467467/references?page=2